Literature DB >> 28483223

Temporal bone extramedullary hematopoiesis as a causeof pediatric bilateral conductive hearing loss:Case report and review of the literature.

Alexander Lanigan1, M Taylor Fordham2.   

Abstract

Extramedullary hematopoiesis occurs in children with hemoglobinopathy and chronic anemia. The liver and spleen are often affected first, but other foci can develop to support erythrocyte demand. We report a case of a nine-year-old with beta thalassemia and temporal bone extramedullary hematopoiesis causing ossicular fixation and bilateral conductive hearing loss. There is only one case in the literature describing this phenomenon in pediatric patients, and this is the first case report of bilateral hearing loss from this physiologic phenomenon. Otolaryngologists should consider this etiology in patients with chronic anemia and conductive hearing loss in the absence of otitis media. Published by Elsevier B.V.

Entities:  

Keywords:  Conductive hearing loss; Extramedullary hematopoiesis; Pediatric

Mesh:

Year:  2017        PMID: 28483223     DOI: 10.1016/j.ijporl.2017.03.032

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  3 in total

1.  A large intrathoracic extramedullary hematopoiesis in alpha-thalassemia: A case report.

Authors:  Jianan Chen; Yuan-Ling Liu; Min-Zhen Lu; Xing-Lin Gao
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 2.  Hearing Loss in Beta-Thalassemia: Systematic Review.

Authors:  Immacolata Tartaglione; Roberta Carfora; Davide Brotto; Maria Rosaria Barillari; Giuseppe Costa; Silverio Perrotta; Renzo Manara
Journal:  J Clin Med       Date:  2021-12-25       Impact factor: 4.241

3.  Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review.

Authors:  Eihab A Subahi; Fateen Ata; Hassan Choudry; Phool Iqbal; Mousa A AlHiyari; Ashraf T Soliman; Vincenzo De Sanctis; Mohamed A Yassin
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.